aluates Reports

$ 0.0

Automative

Global Cancer Pain Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-36C7901

Global Cancer Pain Market Insights and Forecast to 2028

BUY CHAPTERS

Global Cancer Pain Market Insights, Forecast to 2030

Code: QYRE-Auto-36C7901

Report

September 2024

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

BioDelivery Science

ProStrakan Group

Teva Pharmaceuticals

Eli Lilly

Grunenthal Group

GW Pharmaceuticals

Johnson & Johnson

Meda Pharmaceuticals

Orexo

Sanofi

WEX Pharmaceuticals

Cancer Pain Market Size

The global Cancer Pain market is projected to grow from US$ 6321 million in 2024 to US$ 8568 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Cancer Pain Market

Cancer pain is one of the most common symptoms in cancer patients. Pain can be caused by cancer, cancer treatment, or a combination of factors.

Market Analysis and Insights: Global Cancer Pain Market

The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.

Report Covers:

This report presents an overview of global market for Cancer Pain market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cancer Pain, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Pain, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer Pain revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer Pain market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cancer Pain revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cancer Pain Market Report

Report Metric	Details
Report Name	Cancer Pain Market
Accounted market size in 2024	US$ 6321 million
Forecasted market size in 2030	US$ 8568 million
CAGR	5.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Opioids Non-Steroidal Anti-Inflammatory Drugs Others
Segment by Application	Radiotherapy Chemotherapy Hormone Therapy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals, Orexo, Sanofi, WEX Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Pain in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Pain companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Pain revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Cancer Pain Market growing?

Ans: The Cancer Pain Market witnessing a CAGR of 5.2 during the forecast period 2024-2030.

What is the Cancer Pain Market size in 2030?

Ans: The Cancer Pain Market size in 2030 will be US$ 8568 million.

Who are the main players in the Cancer Pain Market report?

Ans: The main players in the Cancer Pain Market are BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals, Orexo, Sanofi, WEX Pharmaceuticals

What are the Application segmentation covered in the Cancer Pain Market report?

Ans: The Applications covered in the Cancer Pain Market report are Radiotherapy, Chemotherapy, Hormone Therapy, Others

What are the Type segmentation covered in the Cancer Pain Market report?

Ans: The Types covered in the Cancer Pain Market report are Opioids, Non-Steroidal Anti-Inflammatory Drugs, Others

Recommended Reports

Cancer Treatment

Pain Management

Cancer Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Pain Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Opioids

1.2.3 Non-Steroidal Anti-Inflammatory Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Cancer Pain Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Radiotherapy

1.3.3 Chemotherapy

1.3.4 Hormone Therapy

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Pain Market Perspective (2019-2030)

2.2 Global Cancer Pain Growth Trends by Region

2.2.1 Cancer Pain Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Pain Historic Market Size by Region (2019-2024)

2.2.3 Cancer Pain Forecasted Market Size by Region (2025-2030)

2.3 Cancer Pain Market Dynamics

2.3.1 Cancer Pain Industry Trends

2.3.2 Cancer Pain Market Drivers

2.3.3 Cancer Pain Market Challenges

2.3.4 Cancer Pain Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cancer Pain by Players

3.1.1 Global Cancer Pain Revenue by Players (2019-2024)

3.1.2 Global Cancer Pain Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cancer Pain, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Cancer Pain Market Concentration Ratio

3.4.1 Global Cancer Pain Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Pain Revenue in 2023

3.5 Global Key Players of Cancer Pain Head office and Area Served

3.6 Global Key Players of Cancer Pain, Product and Application

3.7 Global Key Players of Cancer Pain, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Pain Breakdown Data by Type

4.1 Global Cancer Pain Historic Market Size by Type (2019-2024)

4.2 Global Cancer Pain Forecasted Market Size by Type (2025-2030)

5 Cancer Pain Breakdown Data by Application

5.1 Global Cancer Pain Historic Market Size by Application (2019-2024)

5.2 Global Cancer Pain Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Pain Market Size (2019-2030)

6.2 North America Cancer Pain Market Size by Type

6.2.1 North America Cancer Pain Market Size by Type (2019-2024)

6.2.2 North America Cancer Pain Market Size by Type (2025-2030)

6.2.3 North America Cancer Pain Market Share by Type (2019-2030)

6.3 North America Cancer Pain Market Size by Application

6.3.1 North America Cancer Pain Market Size by Application (2019-2024)

6.3.2 North America Cancer Pain Market Size by Application (2025-2030)

6.3.3 North America Cancer Pain Market Share by Application (2019-2030)

6.4 North America Cancer Pain Market Size by Country

6.4.1 North America Cancer Pain Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Cancer Pain Market Size by Country (2019-2024)

6.4.3 North America Cancer Pain Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Cancer Pain Market Size (2019-2030)

7.2 Europe Cancer Pain Market Size by Type

7.2.1 Europe Cancer Pain Market Size by Type (2019-2024)

7.2.2 Europe Cancer Pain Market Size by Type (2025-2030)

7.2.3 Europe Cancer Pain Market Share by Type (2019-2030)

7.3 Europe Cancer Pain Market Size by Application

7.3.1 Europe Cancer Pain Market Size by Application (2019-2024)

7.3.2 Europe Cancer Pain Market Size by Application (2025-2030)

7.3.3 Europe Cancer Pain Market Share by Application (2019-2030)

7.4 Europe Cancer Pain Market Size by Country

7.4.1 Europe Cancer Pain Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Cancer Pain Market Size by Country (2019-2024)

7.4.3 Europe Cancer Pain Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cancer Pain Market Size (2019-2030)

8.2 China Cancer Pain Market Size by Type

8.2.1 China Cancer Pain Market Size by Type (2019-2024)

8.2.2 China Cancer Pain Market Size by Type (2025-2030)

8.2.3 China Cancer Pain Market Share by Type (2019-2030)

8.3 China Cancer Pain Market Size by Application

8.3.1 China Cancer Pain Market Size by Application (2019-2024)

8.3.2 China Cancer Pain Market Size by Application (2025-2030)

8.3.3 China Cancer Pain Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cancer Pain Market Size (2019-2030)

9.2 Asia Cancer Pain Market Size by Type

9.2.1 Asia Cancer Pain Market Size by Type (2019-2024)

9.2.2 Asia Cancer Pain Market Size by Type (2025-2030)

9.2.3 Asia Cancer Pain Market Share by Type (2019-2030)

9.3 Asia Cancer Pain Market Size by Application

9.3.1 Asia Cancer Pain Market Size by Application (2019-2024)

9.3.2 Asia Cancer Pain Market Size by Application (2025-2030)

9.3.3 Asia Cancer Pain Market Share by Application (2019-2030)

9.4 Asia Cancer Pain Market Size by Region

9.4.1 Asia Cancer Pain Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Cancer Pain Market Size by Region (2019-2024)

9.4.3 Asia Cancer Pain Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cancer Pain Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Cancer Pain Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cancer Pain Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Cancer Pain Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Cancer Pain Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Cancer Pain Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cancer Pain Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Cancer Pain Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Cancer Pain Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Cancer Pain Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cancer Pain Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Cancer Pain Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Cancer Pain Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 BioDelivery Science

11.1.1 BioDelivery Science Company Details

11.1.2 BioDelivery Science Business Overview

11.1.3 BioDelivery Science Cancer Pain Introduction

11.1.4 BioDelivery Science Revenue in Cancer Pain Business (2019-2024)

11.1.5 BioDelivery Science Recent Developments

11.2 ProStrakan Group

11.2.1 ProStrakan Group Company Details

11.2.2 ProStrakan Group Business Overview

11.2.3 ProStrakan Group Cancer Pain Introduction

11.2.4 ProStrakan Group Revenue in Cancer Pain Business (2019-2024)

11.2.5 ProStrakan Group Recent Developments

11.3 Teva pharmaceuticals

11.3.1 Teva pharmaceuticals Company Details

11.3.2 Teva pharmaceuticals Business Overview

11.3.3 Teva pharmaceuticals Cancer Pain Introduction

11.3.4 Teva pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.3.5 Teva pharmaceuticals Recent Developments

11.4 Eli-Lilly

11.4.1 Eli-Lilly Company Details

11.4.2 Eli-Lilly Business Overview

11.4.3 Eli-Lilly Cancer Pain Introduction

11.4.4 Eli-Lilly Revenue in Cancer Pain Business (2019-2024)

11.4.5 Eli-Lilly Recent Developments

11.5 Grunenthal Group

11.5.1 Grunenthal Group Company Details

11.5.2 Grunenthal Group Business Overview

11.5.3 Grunenthal Group Cancer Pain Introduction

11.5.4 Grunenthal Group Revenue in Cancer Pain Business (2019-2024)

11.5.5 Grunenthal Group Recent Developments

11.6 GW Pharmaceuticals

11.6.1 GW Pharmaceuticals Company Details

11.6.2 GW Pharmaceuticals Business Overview

11.6.3 GW Pharmaceuticals Cancer Pain Introduction

11.6.4 GW Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.6.5 GW Pharmaceuticals Recent Developments

11.7 Johnson＆Johnson

11.7.1 Johnson＆Johnson Company Details

11.7.2 Johnson＆Johnson Business Overview

11.7.3 Johnson＆Johnson Cancer Pain Introduction

11.7.4 Johnson＆Johnson Revenue in Cancer Pain Business (2019-2024)

11.7.5 Johnson＆Johnson Recent Developments

11.8 Meda Pharmaceuticals

11.8.1 Meda Pharmaceuticals Company Details

11.8.2 Meda Pharmaceuticals Business Overview

11.8.3 Meda Pharmaceuticals Cancer Pain Introduction

11.8.4 Meda Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.8.5 Meda Pharmaceuticals Recent Developments

11.9 Orexo

11.9.1 Orexo Company Details

11.9.2 Orexo Business Overview

11.9.3 Orexo Cancer Pain Introduction

11.9.4 Orexo Revenue in Cancer Pain Business (2019-2024)

11.9.5 Orexo Recent Developments

11.10 Sanofi

11.10.1 Sanofi Company Details

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Cancer Pain Introduction

11.10.4 Sanofi Revenue in Cancer Pain Business (2019-2024)

11.10.5 Sanofi Recent Developments

11.11 WEX Pharmaceuticals

11.11.1 WEX Pharmaceuticals Company Details

11.11.2 WEX Pharmaceuticals Business Overview

11.11.3 WEX Pharmaceuticals Cancer Pain Introduction

11.11.4 WEX Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.11.5 WEX Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

BioDelivery Science

ProStrakan Group

Teva Pharmaceuticals

Eli Lilly

Grunenthal Group

GW Pharmaceuticals

Johnson & Johnson

Meda Pharmaceuticals

Orexo

Sanofi

WEX Pharmaceuticals

List of Tables

Table 1. Global Cancer Pain Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Opioids

Table 3. Key Players of Non-Steroidal Anti-Inflammatory Drugs

Table 4. Key Players of Others

Table 5. Global Cancer Pain Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Cancer Pain Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cancer Pain Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cancer Pain Market Share by Region (2019-2024)

Table 9. Global Cancer Pain Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cancer Pain Market Share by Region (2025-2030)

Table 11. Cancer Pain Market Trends

Table 12. Cancer Pain Market Drivers

Table 13. Cancer Pain Market Challenges

Table 14. Cancer Pain Market Restraints

Table 15. Global Cancer Pain Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cancer Pain Revenue Share by Players (2019-2024)

Table 17. Global Top Cancer Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2023)

Table 18. Global Cancer Pain Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Cancer Pain Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Cancer Pain, Headquarters and Area Served

Table 21. Global Key Players of Cancer Pain, Product and Application

Table 22. Global Key Players of Cancer Pain, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cancer Pain Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cancer Pain Revenue Market Share by Type (2019-2024)

Table 26. Global Cancer Pain Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cancer Pain Revenue Market Share by Type (2025-2030)

Table 28. Global Cancer Pain Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cancer Pain Revenue Share by Application (2019-2024)

Table 30. Global Cancer Pain Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cancer Pain Revenue Share by Application (2025-2030)

Table 32. North America Cancer Pain Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Cancer Pain Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Cancer Pain Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Cancer Pain Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Cancer Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Cancer Pain Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Cancer Pain Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Cancer Pain Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Cancer Pain Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Cancer Pain Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Cancer Pain Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Cancer Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Cancer Pain Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Cancer Pain Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Cancer Pain Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Cancer Pain Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Cancer Pain Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Cancer Pain Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Cancer Pain Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Cancer Pain Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Cancer Pain Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Cancer Pain Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Cancer Pain Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Cancer Pain Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Cancer Pain Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Cancer Pain Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cancer Pain Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cancer Pain Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cancer Pain Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Cancer Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Cancer Pain Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Cancer Pain Market Size by Country (2025-2030) & (US$ Million)

Table 64. BioDelivery Science Company Details

Table 65. BioDelivery Science Business Overview

Table 66. BioDelivery Science Cancer Pain Product

Table 67. BioDelivery Science Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 68. BioDelivery Science Recent Developments

Table 69. ProStrakan Group Company Details

Table 70. ProStrakan Group Business Overview

Table 71. ProStrakan Group Cancer Pain Product

Table 72. ProStrakan Group Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 73. ProStrakan Group Recent Developments

Table 74. Teva pharmaceuticals Company Details

Table 75. Teva pharmaceuticals Business Overview

Table 76. Teva pharmaceuticals Cancer Pain Product

Table 77. Teva pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 78. Teva pharmaceuticals Recent Developments

Table 79. Eli-Lilly Company Details

Table 80. Eli-Lilly Business Overview

Table 81. Eli-Lilly Cancer Pain Product

Table 82. Eli-Lilly Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 83. Eli-Lilly Recent Developments

Table 84. Grunenthal Group Company Details

Table 85. Grunenthal Group Business Overview

Table 86. Grunenthal Group Cancer Pain Product

Table 87. Grunenthal Group Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 88. Grunenthal Group Recent Developments

Table 89. GW Pharmaceuticals Company Details

Table 90. GW Pharmaceuticals Business Overview

Table 91. GW Pharmaceuticals Cancer Pain Product

Table 92. GW Pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 93. GW Pharmaceuticals Recent Developments

Table 94. Johnson＆Johnson Company Details

Table 95. Johnson＆Johnson Business Overview

Table 96. Johnson＆Johnson Cancer Pain Product

Table 97. Johnson＆Johnson Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 98. Johnson＆Johnson Recent Developments

Table 99. Meda Pharmaceuticals Company Details

Table 100. Meda Pharmaceuticals Business Overview

Table 101. Meda Pharmaceuticals Cancer Pain Product

Table 102. Meda Pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 103. Meda Pharmaceuticals Recent Developments

Table 104. Orexo Company Details

Table 105. Orexo Business Overview

Table 106. Orexo Cancer Pain Product

Table 107. Orexo Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 108. Orexo Recent Developments

Table 109. Sanofi Company Details

Table 110. Sanofi Business Overview

Table 111. Sanofi Cancer Pain Product

Table 112. Sanofi Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 113. Sanofi Recent Developments

Table 114. WEX Pharmaceuticals Company Details

Table 115. WEX Pharmaceuticals Business Overview

Table 116. WEX Pharmaceuticals Cancer Pain Product

Table 117. WEX Pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 118. WEX Pharmaceuticals Recent Developments

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Pain Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cancer Pain Market Share by Type: 2023 VS 2030

Figure 3. Opioids Features

Figure 4. Non-Steroidal Anti-Inflammatory Drugs Features

Figure 5. Others Features

Figure 6. Global Cancer Pain Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Cancer Pain Market Share by Application: 2023 VS 2030

Figure 8. Radiotherapy Case Studies

Figure 9. Chemotherapy Case Studies

Figure 10. Hormone Therapy Case Studies

Figure 11. Others Case Studies

Figure 12. Cancer Pain Report Years Considered

Figure 13. Global Cancer Pain Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Cancer Pain Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Cancer Pain Market Share by Region: 2023 VS 2030

Figure 16. Global Cancer Pain Market Share by Players in 2023

Figure 17. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Cancer Pain Revenue in 2023

Figure 19. North America Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Cancer Pain Market Share by Type (2019-2030)

Figure 21. North America Cancer Pain Market Share by Application (2019-2030)

Figure 22. North America Cancer Pain Market Share by Country (2019-2030)

Figure 23. United States Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Cancer Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Cancer Pain Market Share by Type (2019-2030)

Figure 27. Europe Cancer Pain Market Share by Application (2019-2030)

Figure 28. Europe Cancer Pain Market Share by Country (2019-2030)

Figure 29. Germany Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Cancer Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Cancer Pain Market Share by Type (2019-2030)

Figure 37. China Cancer Pain Market Share by Application (2019-2030)

Figure 38. Asia Cancer Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Cancer Pain Market Share by Type (2019-2030)

Figure 40. Asia Cancer Pain Market Share by Application (2019-2030)

Figure 41. Asia Cancer Pain Market Share by Region (2019-2030)

Figure 42. Japan Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Cancer Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Cancer Pain Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Cancer Pain Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Cancer Pain Market Share by Country (2019-2030)

Figure 52. Brazil Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. BioDelivery Science Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 59. ProStrakan Group Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 60. Teva pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 61. Eli-Lilly Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 62. Grunenthal Group Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 63. GW Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 64. Johnson＆Johnson Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 65. Meda Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 66. Orexo Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 67. Sanofi Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 68. WEX Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pets Pain Management Market Insights Forecast to 2030

Global Drugs for Pain Management Market Insights Forecast to 2030

Global Prostate Cancer Medicine Market Insights Forecast to 2030

Global Palliative Services Market Insights Forecast to 2030

Global Pets Pain Relief and Prevention Market Insights Forecast to 2030

Global Orthopedic Oncology Treatment Market Insights Forecast to 2030

Advanced Cancer Pain Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Prostate Cancer Market Insights Forecast to 2030

Global Drugs for Osteoarthritis Pain Market Insights Forecast to 2030

Global Non Opioid Pain Treatment Market Insights Forecast to 2030

Global Animal Pain Relief and Prevention Market Insights Forecast to 2030

Bone Pain Treatment Market

Global Blood and Bone Marrow Cancer Treatment Market Insights Forecast to 2030

Global Metastatic Bone Disease Market Insights Forecast to 2030

Global Cancer Infusion Therapy Market Insights Forecast to 2030

Global Postoperative Pain Therapeutics Market Insights Forecast to 2030

Global Medication Treatment of Metastatic Bone Disease Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions